AI in Life Sciences: Practical Use Cases in Key Workflows

AI in life sciences doesn’t need to arrive as one sweeping transformation. Its value is increasingly showing up in smaller, more practical moments across the product lifecycle, where AI helps interpret data, prioritize work, identify quality signals, or guide physical processes.

Those moments have huge potential for transformation, because life sciences organizations already operate through complex systems, regulated workflows, and established decision paths. Adding AI without accounting for that environment can create another disconnected tool. Integrating it well can make existing work faster, clearer, and more consistent.

The most useful AI use cases in life sciences therefore have something in common. They fit into the way work already happens while strengthening the systems around it.

AI in Clinical Trials Brings Research Closer to the Patient

Clinical research has traditionally depended heavily on visits to trial sites, centralized data collection, and scheduled interactions between participants and investigators. Digital health technologies are creating more flexibility by allowing some data to be collected remotely through connected devices, sensors, apps, and other tools. 

FDA guidance on digital health technologies specifically recognizes their use for remote data acquisition in clinical investigations, while decentralized trial guidance covers activities that can take place away from traditional research sites. 

AI in clinical trials can build on that model by helping teams:

• Interpret continuous streams of participant data
• Identify signals that may require attention
• Prioritize unusual patterns for review
• Focus monitoring efforts where they are most useful

Instead of waiting for the next scheduled review, researchers can use analytics to make better use of the data being generated throughout the study.

The opportunity goes beyond making trials more virtual. Remote collection can reduce some of the burden on patients and research sites while creating a richer flow of data across the study. The challenge is making sure digital tools, clinical platforms, and data pipelines work as a connected environment rather than separate technologies.

That requirement makes connected life sciences and healthcare systems an important part of the AI conversation. 

AI Can Surface Manufacturing Quality Signals Earlier

The same principle applies to life sciences manufacturing, where small changes in equipment, materials, process conditions, or environmental factors can become larger quality issues if they aren’t detected early. 

AI can analyze production and quality data as it’s generated, helping teams identify: 

• Abnormal process patterns
• Emerging deviations
• Changes that may affect product quality
• Visual characteristics that warrant further inspection

Computer vision is also beneficial as it monitors characteristics that would otherwise depend on repeated manual inspection. 

The aim isn’t to remove quality teams from the process altogether, but to give them earlier signals and better context. This lets them investigate potential problems before a batch failure, prolonged deviation, or downstream delay occurs.

The FDA has been examining how AI may fit into drug manufacturing and the existing regulatory framework, including questions around model maintenance, data management, and use in CGMP environments.

Those considerations reinforce the point that effective AI has to fit into validated processes, quality controls, and established manufacturing systems.

Existing work on life sciences manufacturing automation and managing CAPAs and quality deviations shows why technology and operating discipline need to move together. 

AI Regulatory Compliance Reduces Manual Review Without Removing Oversight

Regulatory and quality teams manage large volumes of documents, changes, supporting evidence, and review activity. Much of that work requires specialist judgment, but significant time can still be spent searching, comparing, classifying, and routing information before a decision can be made.

AI regulatory compliance use cases can reduce some of that manual burden by helping teams: 

• Compare document versions
• Identify relevant changes
• Classify incoming records
• Summarize supporting information
• Prioritize change controls for expert review

Human sign-off remains essential, especially where decisions affect safety, quality, or regulatory commitments. The role of AI is to make the review process more efficient while keeping accountability with qualified professionals.

The FDA’s current principles for AI in drug development reinforce the need for human-centered design, clear context of use, data governance, risk-based assessment, and lifecycle management when AI contributes to regulated decisions.

Those requirements make the underlying technology environment just as important as the model. AI and data foundations need to connect with document systems, quality platforms, workflows, and governance controls if AI is going to support regulated work reliably.

Physical AI Brings Intelligence Onto the Fulfillment Floor

Prescription fulfillment shows how AI moves beyond digital workflows and into physical operations. 

On a fulfillment floor, AI-guided robotics and computer vision can support several connected activities: 

• Identifying items as they move through the process
• Verifying prescriptions against expected information
• Routing packages through automated systems
• Coordinating movement between physical workstations

Rather than producing an insight for someone to review later, the technology helps guide an action in a physical space.

That distinction makes Physical AI different from many other AI applications. Software, sensors, vision systems, robotics, and operational controls all have to work together with the speed and reliability required by the physical process.

For life sciences leaders, the lesson extends well beyond prescription fulfillment. AI becomes more demanding as soon as a prediction needs to influence a machine, production line, or other physical system. The architecture around the model becomes part of the outcome.

A deeper look at how Physical AI changes systems design shows why integration, resilience, and engineering discipline become increasingly important once AI leaves the screen.

The Common Thread Across AI Use Cases in Life Sciences

Remote trial monitoring, manufacturing quality, regulatory review, and prescription fulfillment appear to be very different AI applications. Underneath them, the same integration challenge keeps appearing.

AI needs access to the right data, but it also needs a reliable place inside the workflow. Teams need to know when AI should make a recommendation, when a person needs to intervene, what happens when confidence is low, and how the result moves into the next system or process.

Strong integration therefore depends on stable alignment across:

• Data quality and governance
• Existing applications and operational systems
• Human review and decision rights
• Validation, security, and regulatory controls
• Workflow design and ongoing monitoring

The life sciences organizations that get the most practical value from AI are likely to be the ones that treat those connections as part of the design from the beginning.

Systems integration and interoperability provide the foundation that allows individual AI use cases to become part of day-to-day operations instead of getting stuck as isolated pilots. 

Turning Practical AI Into Connected Life Sciences Operations 

AI in life sciences won’t arrive as one dramatic transformation. It’ll most likely build through targeted improvements across research, manufacturing, regulatory work, and physical operations, with each use case solving a clear workflow problem. 

Our teams helps life sciences organizations do the integration work behind those outcomes, connecting AI, data, applications, engineering systems, and regulated workflows so new capabilities can fit into the environment already in place.

If your organization is exploring practical AI opportunities across the life sciences lifecycle, contact the Akkodis team to discuss where integration can turn individual use cases into sustainable operational value.